WEKO3
アイテム
{"_buckets": {"deposit": "890f20c8-71ba-4913-80bc-0578428bffca"}, "_deposit": {"id": "12019", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "12019"}, "status": "published"}, "_oai": {"id": "oai:niigata-u.repo.nii.ac.jp:00012019", "sets": ["456", "1012"]}, "item_7_alternative_title_1": {"attribute_name": "その他のタイトル", "attribute_value_mlt": [{"subitem_alternative_title": "Multimodality Therapy for Lung Cancer"}]}, "item_7_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2006-08", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "8", "bibliographicPageEnd": "429", "bibliographicPageStart": "425", "bibliographicVolumeNumber": "120", "bibliographic_titles": [{"bibliographic_title": "新潟医学会雑誌"}, {"bibliographic_title": "新潟医学会雑誌", "bibliographic_titleLang": "en"}]}]}, "item_7_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Lung cancer is the leading cause of cancer mortality in the world. In Japan, lung cancer was responsible for 41634 of men and 15086 of women death in 2003, accounting for 18.3% of all cancer death each year and approximately 100,000 death will occur in 2010. Despite chemotherapy with new agents have been shown to improve the survival and quality of life in patients with lung cancer, curable patient is still rare. Molecular target therapy, cellular therapy could be powerful arms to overcome this stagnant situation. Moreover, combination of these treatment modalities, i.e., multimodality therapy should improve the prognosis of patients with lung cancer.", "subitem_description_type": "Abstract"}]}, "item_7_full_name_3": {"attribute_name": "著者別名", "attribute_value_mlt": [{"nameIdentifiers": [{"nameIdentifier": "80959", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Yoshizawa, Hiroshisa"}]}]}, "item_7_publisher_7": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "新潟医学会"}]}, "item_7_rights_15": {"attribute_name": "権利", "attribute_value_mlt": [{"subitem_rights": "本文データは学協会の許諾に基づきCiNiiから複製したものである"}]}, "item_7_select_19": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_select_item": "publisher"}]}, "item_7_source_id_11": {"attribute_name": "書誌レコードID", "attribute_value_mlt": [{"subitem_source_identifier": "AN00182415", "subitem_source_identifier_type": "NCID"}]}, "item_7_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "00290440", "subitem_source_identifier_type": "ISSN"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "吉澤, 弘久"}], "nameIdentifiers": [{"nameIdentifier": "80958", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2019-08-07"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "110006483470.pdf", "filesize": [{"value": "590.7 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 590700.0, "url": {"label": "110006483470.pdf", "url": "https://niigata-u.repo.nii.ac.jp/record/12019/files/110006483470.pdf"}, "version_id": "486067f2-898c-4120-b528-60ba9c9c6b4b"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "lung cancer", "subitem_subject_scheme": "Other"}, {"subitem_subject": "chemotherapy", "subitem_subject_scheme": "Other"}, {"subitem_subject": "molecular target", "subitem_subject_scheme": "Other"}, {"subitem_subject": "cellular therapy", "subitem_subject_scheme": "Other"}, {"subitem_subject": "multimodality therapy", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "departmental bulletin paper", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "肺癌に対する集学的治療", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "肺癌に対する集学的治療"}, {"subitem_title": "肺癌に対する集学的治療", "subitem_title_language": "en"}]}, "item_type_id": "7", "owner": "1", "path": ["456", "1012"], "permalink_uri": "http://hdl.handle.net/10191/19862", "pubdate": {"attribute_name": "公開日", "attribute_value": "2012-10-17"}, "publish_date": "2012-10-17", "publish_status": "0", "recid": "12019", "relation": {}, "relation_version_is_last": true, "title": ["肺癌に対する集学的治療"], "weko_shared_id": null}
肺癌に対する集学的治療
http://hdl.handle.net/10191/19862
http://hdl.handle.net/10191/19862adb1efaf-c322-4687-9c67-b6661deff4e7
名前 / ファイル | ライセンス | アクション |
---|---|---|
110006483470.pdf (590.7 kB)
|
|
Item type | 紀要論文 / Departmental Bulletin Paper(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2012-10-17 | |||||
タイトル | ||||||
タイトル | 肺癌に対する集学的治療 | |||||
タイトル | ||||||
言語 | en | |||||
タイトル | 肺癌に対する集学的治療 | |||||
言語 | ||||||
言語 | jpn | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | lung cancer | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | chemotherapy | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | molecular target | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | cellular therapy | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | multimodality therapy | |||||
資源タイプ | ||||||
資源 | http://purl.org/coar/resource_type/c_6501 | |||||
タイプ | departmental bulletin paper | |||||
その他のタイトル | ||||||
その他のタイトル | Multimodality Therapy for Lung Cancer | |||||
著者 |
吉澤, 弘久
× 吉澤, 弘久 |
|||||
著者別名 | ||||||
識別子 | 80959 | |||||
識別子Scheme | WEKO | |||||
姓名 | Yoshizawa, Hiroshisa | |||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Lung cancer is the leading cause of cancer mortality in the world. In Japan, lung cancer was responsible for 41634 of men and 15086 of women death in 2003, accounting for 18.3% of all cancer death each year and approximately 100,000 death will occur in 2010. Despite chemotherapy with new agents have been shown to improve the survival and quality of life in patients with lung cancer, curable patient is still rare. Molecular target therapy, cellular therapy could be powerful arms to overcome this stagnant situation. Moreover, combination of these treatment modalities, i.e., multimodality therapy should improve the prognosis of patients with lung cancer. | |||||
書誌情報 |
新潟医学会雑誌 en : 新潟医学会雑誌 巻 120, 号 8, p. 425-429, 発行日 2006-08 |
|||||
出版者 | ||||||
出版者 | 新潟医学会 | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 00290440 | |||||
書誌レコードID | ||||||
収録物識別子タイプ | NCID | |||||
収録物識別子 | AN00182415 | |||||
権利 | ||||||
権利情報 | 本文データは学協会の許諾に基づきCiNiiから複製したものである | |||||
著者版フラグ | ||||||
値 | publisher |